PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsInsulin glulisine
Apidra(insulin glulisine)
Apidra (insulin glulisine) is a protein pharmaceutical. Insulin glulisine was first approved as Apidra on 2004-04-16. It has been approved in Europe to treat diabetes mellitus.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
endocrine system diseasesD004700
Trade Name
FDA
EMA
Apidra (discontinued: Apidra)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Insulin glulisine
Tradename
Proper name
Company
Number
Date
Products
Apidrainsulin glulisineSanofiN-21629 RX2004-04-16
2 products
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
apidra2008-11-06
apidra apidra solostarBiologic Licensing Application2023-07-25
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A10: Drugs used in diabetes
A10A: Insulins and analogues
A10AB: Insulins and analogues for injection, fast-acting
A10AB06: Insulin glulisine
HCPCS
No data
Clinical
Clinical Trials
123 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13811822150
Type 2 diabetes mellitusD003924EFO_0001360E1121020133
Type 1 diabetes mellitusD003922EFO_0001359E10489324
HyperglycemiaD006943R73.91348
Renal insufficiencyD051437N1922
LipodystrophyD008060E88.111
Liver cirrhosisD008103EFO_0001422K74.011
FibrosisD00535511
KetosisD007662R82.411
AcidosisD000138EFO_1000014E87.211
Show 1 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C9511
Myocardial infarctionD009203EFO_0000612I2111
St elevation myocardial infarctionD00007265711
InfarctionD007238EFO_000946311
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gestational diabetesD016640O24.411
Pregnancy in diabeticsD011254O24.9111
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetic nephropathiesD003928EFO_000040111
Kidney diseasesD007674EFO_0003086N0811
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
Lung diseasesD008171EFO_0003818J98.411
Obstructive lung diseasesD00817311
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameInsulin glulisine
INNinsulin glulisine
Description
Insulin glulisine recombinant
Classification
Protein
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB6GV0
CAS-ID
RxCUI
ChEMBL IDCHEMBL1201613
ChEBI ID
PubChem CID
DrugBankDB01309
UNII ID7XIY785AZD (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Insulin glulisine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,077 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
6,010 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use